These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion. Laib AK; BrĂ¼nen S; Pfeifer P; Vincent P; Hiemke C Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. Wisner KL; Perel JM J Clin Psychopharmacol; 1998 Apr; 18(2):167-9. PubMed ID: 9555601 [TBL] [Abstract][Full Text] [Related]
4. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Fokina VM; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN Am J Obstet Gynecol; 2016 Oct; 215(4):497.e1-7. PubMed ID: 27180885 [TBL] [Abstract][Full Text] [Related]
5. Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status. Gaebler AJ; Schneider KL; Stingl JC; Paulzen M Pharmacogenomics J; 2020 Dec; 20(6):840-844. PubMed ID: 32475982 [TBL] [Abstract][Full Text] [Related]
9. Estimates of nursing infant daily dose of fluoxetine through breast milk. Suri R; Stowe ZN; Hendrick V; Hostetter A; Widawski M; Altshuler LL Biol Psychiatry; 2002 Sep; 52(5):446-51. PubMed ID: 12242061 [TBL] [Abstract][Full Text] [Related]
10. Bupropion and breastfeeding: a case of a possible infant seizure. Chaudron LH; Schoenecker CJ J Clin Psychiatry; 2004 Jun; 65(6):881-2. PubMed ID: 15291673 [No Abstract] [Full Text] [Related]
12. Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Al-Abri SA; Orengo JP; Hayashi S; Thoren KL; Benowitz NL; Olson KR Clin Toxicol (Phila); 2013 Dec; 51(10):1230-4. PubMed ID: 24131328 [TBL] [Abstract][Full Text] [Related]
13. Use of antidepressants by nursing mothers. Agell I Br J Psychiatry; 2002 Jan; 180():85-6. PubMed ID: 11772860 [No Abstract] [Full Text] [Related]
14. Bupropion plasma levels and CYP2D6 phenotype. Pollock BG; Sweet RA; Kirshner M; Reynolds CF Ther Drug Monit; 1996 Oct; 18(5):581-5. PubMed ID: 8885123 [TBL] [Abstract][Full Text] [Related]
15. Bupropion SR for the treatment of postpartum depression: a pilot study. Nonacs RM; Soares CN; Viguera AC; Pearson K; Poitras JR; Cohen LS Int J Neuropsychopharmacol; 2005 Sep; 8(3):445-9. PubMed ID: 15817137 [TBL] [Abstract][Full Text] [Related]
16. Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography. Suckow RF; Zhang MF; Cooper TB Biomed Chromatogr; 1997; 11(3):174-9. PubMed ID: 9192113 [TBL] [Abstract][Full Text] [Related]
17. Steady-state clinical pharmacokinetics of bupropion extended-release in youths. Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996 [TBL] [Abstract][Full Text] [Related]
18. Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS. Coles R; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):67-75. PubMed ID: 17656162 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy. Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma. Teitelbaum AM; Flaker AM; Kharasch ED J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]